Life ScienceCompany
Who owns Aardvark Therapeutics - ARD-301?
Aardvark Therapeutics - ARD-301 is owned by SCILEX Pharmaceuticals and Sorrento Therapeutics. It was acquired in 2021.
Aardvark Therapeutics - ARD-301 is owned by SCILEX Pharmaceuticals and Sorrento Therapeutics. It was acquired in 2021.
San Diego, California
92130
United States,
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2021-03-01 | Sorrento Therapeutics, SCILEX Pharmaceuticals, Inc. | |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
